Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL)
Conditions
Acute Stress Reaction · Acute Stress Disorder · Neurocognitive Function · Post-traumatic Stress
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Alabama at Birmingham, Birmingham, Alabama, United States
Contact: Study coordinator (Whitney Taylor)Contact: Principal Investigator (Lauren Walter)Indiana University, Indianapolis, Indiana, United States
Contact: Principal Investigator (Paul Musey, MD)University of Kansas Medical Center, Kansas City, Kansas, United States
Contact: Principal Investigator (Lindsay Maguire, MD)Chad Cannon, MD (Sub-investigator)Washington University in St. Louis, St Louis, Missouri, United States
Contact: Principal Investigator (Stacey House, MD)Cooper University Health System, Camden, New Jersey, United States
Contact: Study coordinator (Dylan Kurowsky)Contact: Principal Investigator (Christopher Jones)The Ohio State University, Columbus, Ohio, United States
Contact: Study coordinator (Hawa Sall)Contact: Principal Investigator (Michael Lyons)Rhode Island Hospital, Providence, Rhode Island, United States
Contact: Principal Investigator (Adam Aluisio, MD)The Miriam Hospital, Providence, Rhode Island, United States
Contact: Principal Investigator (Adam Aluisio, MD)University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
Contact: Study coordinator (Stephanie Perez)Contact: Principal Investigator (Ralph Riviello)
Study leads
Samuel McLean, MD
Principal Investigator
University of North Carollina at Chapel Hill
Christopher Jones, MD
Principal Investigator
Cooper University Health Care